Detalhe da pesquisa
1.
Ganglioneuromas across age groups: Systematic review of individual patient data.
Clin Endocrinol (Oxf)
; 94(1): 12-23, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32702779
2.
Pheochromocytoma and paraganglioma: genotype versus anatomic location as determinants of tumor phenotype.
Cell Tissue Res
; 372(2): 347-365, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29362886
3.
Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function.
FASEB J
; 26(11): 4506-16, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22835832
4.
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6).
Target Oncol
; 18(5): 749-765, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37488307
5.
Primary refractory plasmablastic lymphoma: A precision oncology approach.
Front Oncol
; 13: 1129405, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36923431
6.
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
Endocr Relat Cancer
; 30(12)2023 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37902037
7.
Responses to systemic therapy in metastatic pheochromocytoma/paraganglioma: a retrospective multicenter cohort study.
Eur J Endocrinol
; 189(5): 546-565, 2023 Nov 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37949483
8.
Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
J Clin Endocrinol Metab
; 108(10): 2676-2685, 2023 09 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36946182
9.
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Nat Commun
; 14(1): 1122, 2023 02 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36854674
10.
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Front Endocrinol (Lausanne)
; 13: 1070074, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36760809
11.
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion.
Discov Oncol
; 12(1): 9, 2021 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35201450
12.
Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.
Front Endocrinol (Lausanne)
; 12: 589451, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33776908
13.
Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.
Cell Tissue Res
; 340(3): 607-12, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20440513
14.
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
Endocr Relat Cancer
; 27(11): 625-640, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33112842
15.
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
J Clin Endocrinol Metab
; 105(10)2020 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32750708
16.
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
J Mol Diagn
; 19(4): 575-588, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28552549
17.
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
Neoplasia
; 18(9): 567-76, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27659016
18.
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
J Mol Med (Berl)
; 93(1): 93-104, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25263965
19.
Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
PLoS One
; 9(5): e97712, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24846270
20.
Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
Neoplasia
; 15(4): 435-47, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23555188